Implandata Ophthalmic Products, a digital health eye care company has been selected as Top 12 Health Techpreneur at the Healthcare Innovation World Cup at Medica.

Out of more than 300 competitors, Implandata has been awarded as a leading breakthrough health care innovator and was invited to present its disruptive Eyemate solution on 15^th November 2021 at Medica Connected Health Care Forum.

Implandata’s proprietary EYEMATE system is a clinically validated and CE marked product for remote glaucoma care. US FDA Breakthrough Device Designation was obtained earlier in 2021. The system allows patients to self-measure critical disease parameters, and then automatically sends gathered information in real-time to their eye doctors. This information enables eye doctors to obtain timely information about therapy effectiveness and to remotely adjust treatment based on a patient’s current condition rather than make therapeutic adjustments based on only infrequent office visits.